Describe symptoms and prevalence of two disorders (anxiety, affective, or eating disorders)
Neuropharmacology: Affective Disorders
-
Upload
brian-piper -
Category
Education
-
view
699 -
download
3
description
Transcript of Neuropharmacology: Affective Disorders
![Page 1: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/1.jpg)
Affective Disorders
Brian J. Piper, Ph.D., M.S.
![Page 2: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/2.jpg)
Goals
• Serotonin (5-HT)• Major Depressive Disorder• Bipolar Disorder
![Page 3: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/3.jpg)
Major Depressive Disorder
• Five + (1 or 2) causing significant social or occupational impairment not due to medical condition– 1) Depressed mood most of the day, nearly every day– 2) Marked diminished interest or pleasure, in activities– 3) Significant weight loss/gain (+5%/month)– 4) Insomnia/hypersomnia– 5) Fatigue or loss of energy– 6) Diminished ability to think or concentrate– 7) recurrent thoughts of death, suicidal attempt/plan
Anna M. Kring, Ph.D. Lecture 14, 19:38-23:08
![Page 4: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/4.jpg)
Edvard Munch (1863-1944)
Despair (1894)
Vincent van Gogh (1853-1890)
Sorrowing Old Man (‘At Eternity’s Gate’)1890
![Page 5: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/5.jpg)
MDD
• Episode = 6 months• Female: Males (2:1)• Age of Onset (younger)
![Page 6: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/6.jpg)
Heritability
BMJ 1999; 319 : 37
![Page 7: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/7.jpg)
Biosynthesis
HO: hydroxylCOOH: carboxyl
![Page 8: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/8.jpg)
Biosynthesis
Tryptophan: yogurt, milk, fish, nuts
Tryptophan hydroxylase: rate limitingstep
![Page 9: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/9.jpg)
![Page 10: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/10.jpg)
Role of 5-HT in MDD
• Methods: 15 un-medicated women with a history of 2+ episodes of depression were on a low protein diet for 1 week, then randomly assigned to receive:– Tryptophan + : L-tryptophan (1.9 g), L-alanine (4.6
g) L-arginine (4.1 g)
– Tryptophan - : L-alanine (4.6 g) L-arginine (4.1 g)
![Page 11: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/11.jpg)
Hamilton Depression Inventory
http://www.psy-world.com/online_hamd.htm
![Page 12: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/12.jpg)
Ham-D
http://www.psy-world.com/online_hamd.htm
Max Hamilton
1912-1988
![Page 13: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/13.jpg)
Smith et al. (1997). Lancet, 349, 915-919.
![Page 14: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/14.jpg)
Smith et al. (1997). Lancet, 349, 915-919.
![Page 15: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/15.jpg)
5-HT & Aggression
• Para-chlorophenylalanine (PCPA): irreversible tryptophan hydroxylase inhibitor
• PCPA treated rats were tested for muricide
Killers Non-killers
Control 0 13
PCPA 14 4
Paxinos et al. (1977). Pharmacology, Biochemistry, Behavior, 6, 439-447.
![Page 16: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/16.jpg)
5-HT & Aggression• muricide: mouse killing• PCPA: aggression• PCPA + 5-HTP: no
aggression
Paxinos et al. (1977). Pharmacology, Biochemistry, Behavior, 6, 439-447.
![Page 17: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/17.jpg)
Serotonergic Projects
• Cell bodies in Raphe
• Projections throughout CNS
![Page 18: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/18.jpg)
5-HT Functions
Spinal Cord Sexual dysfunction
Brain stem Nausea
Modified from Stahl (2001) p. 182
![Page 19: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/19.jpg)
5-HT Functions
Limbic Anxiety
Brain stem Insomnia
Modified from Stahl (2001) p. 182
![Page 20: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/20.jpg)
5-HT Functions
Frontal Cortex Mood
Hypothalamus Appetite (Bulimia?)
Modified from Stahl (2001) p. 182
![Page 21: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/21.jpg)
Fenfluramine• Fenfluramine is a 5-HT releaser that was used
with phentermine for weight control• Animal studies indicate fenfluramine causes 5-HT
axotomy• Methods: Former fenfluramine users (N=15) and
controls (N=17) completed PET imaging
McCann et al. (2007). Molecular Imaging & Biology, 9, 151-157.
![Page 22: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/22.jpg)
5-HT Receptors
Postsynaptic1A1B2A2C4567
Presynaptic1A
![Page 23: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/23.jpg)
5-HT1A Agonist: 8-OH-DPAT
• Example#1: Rats received MDMA from age 35 to 60• A 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin)
challenge was administered at age 67
Piper et al. (2006) JPET, 317, 838-849.
![Page 24: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/24.jpg)
5-HT2A Agonist: DOI
• Example #2: Rats received MDMA from age 35 to 60
• A DOI (di-methoxy-4-iodophenyl)-2-aminopropane) challenge was administered at age 67
Biezonski et al. (2009) Brain Research, 1252, 87-93.
![Page 25: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/25.jpg)
MAO-Is
• Monoamine Oxidase (MAO) is an enzyme that breaks down 5-HT, NE, & DA
![Page 26: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/26.jpg)
MAO-Is
• Monoamine Oxidase (MAO) is an enzyme that breaks down 5-HT, NE, & DA; peak use in 1970s
• Food Interactions: – Tyramine: amino acid breakdown product of
tyrosine, doesn’t cross BBB but causes norepinephrine release
– Tyramine rich foods (aged cheese, beer, wine) + MAO-I results in increased blood pressure & headaches (“cheese effect”)
![Page 27: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/27.jpg)
MAO-Is
• Monoamine Oxidase (MAO) is an enzyme that breaks down 5-HT, NE, & DA
• Food Interactions: tyramine foods (aged cheese, beer, wine) results in increased norepinephrine (blood pressure)
• Drug Interactions: increased activity of drugs that elevated 5-HT, NE, DA (cocaine, hypericum, ritalin)
• 1st generation were irreversible inhibitors (1960s), 2nd generation are reversible inhibitors
![Page 28: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/28.jpg)
Tricyclic Antidepressants
• Developed from antipsychotic drugs• Have 3 ringed structure
![Page 29: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/29.jpg)
SERT & NET Blockade+
![Page 30: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/30.jpg)
Serotonin Reuptake Inhibitors
• Prozac (fluoxetine) was the original SRI• Greater affinity for SERT than NET• Not Selective (sigma receptors, CYP2D6)• Anorgasmia
![Page 31: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/31.jpg)
ComparisonMAO-Is TCA SSRIs
Efficacy Moderate Moderate Low
Side-effects “cheese effect”, many drug interactions
orthostatic hypertension, OD
Sexual, DiscontinuationSyndrome
Prevalence very low low high
Mechanism 5-HT, NE, DA 5-HT & NE 5-HT
Therapeutic Lag Yes Yes Yes
![Page 32: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/32.jpg)
Other Mechanisms of Antidepressants
• 5-HT2
• Intracellelar (e.g. cAMP)• Brain Derived Neurotrophic Factor
![Page 33: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/33.jpg)
Cortisol
• The Hypothalamus-Pituitary-Adrenal (HPA) axis control release of the stress hormone cortisol.
• As many as half of depressed patients show elevations in cortisol. Drugs that turn off the HPA axis are ineffective.
Belmaker & Agam (2008). New England Journal of Medicine, 358, 55-68.
![Page 34: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/34.jpg)
Structural Changes following Elevated Cortisol?
• Rat research indicate that persistent increases in cortisol are toxic to hippocampal neurons.
• Studies examining the volume of the hippocampus in MDD were inconsistent.• A meta-analysis showed that the left (-4.5%) and right hippocampus (-4.0%)
showed reductions.
Cole et al. (2011). J of Affective Dis 134, 483-487.
![Page 35: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/35.jpg)
Antidepressants & Neurogenesis
• New neurons are produced in the hippocampus in adults
ECS: electroconvulsive therapy; TCP: trancyclpromine (MAO-I), or Reboxetine (SNRI)
Mahlberg (2000). J Neurosciece, 20, 9104-9110.
![Page 36: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/36.jpg)
Electroconvulsive Therapy
• The most effective treatment for MDD (especially high suicide risk)
• Controversial!• Potential memory loss• George, David T. (2011). Electroconvulsive therapy. Starts at
54:50: http://videocast.nih.gov/Summary.asp?File=16674
![Page 37: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/37.jpg)
Cognitive Behavioral Therapy
• Short, evidence based, therapy• Developed by Aaron T. Beck• Instruction in how thoughts & feelings
influence behavior
1921-
![Page 38: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/38.jpg)
CBT + Medication• Patients randomized to receive Nefazodone (5-
HT2A/1 antagonist), CBT, or both for 3 months
Nef CBT Nef +CBTCompleters 69.5% 72.2% 76.5%
No Response 44% 48% 15%Remission 22% 24% 42%
Keller et al (2000). New England J of Medicine, 342, 1462-1470.
![Page 39: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/39.jpg)
Diagnosis of Bipolar
• Bipolar I: – manic episode– depression not
required– not due to
recreational drugs
• Bipolar II:– Hypomanic Episode– major depressive episode– not due to recreational
drugs
![Page 40: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/40.jpg)
Example of Mania
• Lifetime prevalence: 1% • 1st Minute:
http://www.youtube.com/watch?v=rcl09ztmoDw
![Page 41: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/41.jpg)
Moreno, C. et al. (2007). Arch Gen Psychiatry, 64, 1032-1039.
National trends in visits with a diagnosis of bipolar disorder as a percentage of total office-based visits by youth (aged 0-19 years) and adults (aged >= 20 years)
![Page 42: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/42.jpg)
Bipolar Disorder
Many great writers, poets, and composers suffered from bipolar disorder.
During their manic phase creativity surged, but not during their depressed
phase.
Whitman Wolfe Clemens Hemingway
Bettm
ann/ Corbis
George C
. Beresford/ H
ulton Getty P
ictures Library
The G
ranger Collection
Earl T
heissen/ Hulton G
etty Pictures L
ibrary
![Page 43: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/43.jpg)
Treatment
• Lithium carbonate (Li2CO3)• John Cade, Australian psychiatrist, on giving
lithium to guinea pigs:– “After a latent period of about two-hours, the animals, although fully conscious
became extremely lethargic and unresponsive to stimuli for one to two hours before once again becoming timid and active. Those who have experimented with guinea pigs know to what extent a ready startle reaction is part of their makeup. It was even more startling to find that after the injection of a solution of lithium carbonate they could be turned on their backs and that, instead of the usual frantic righting behavior, they merely lay there and gazed placidly back at him.”
![Page 44: Neuropharmacology: Affective Disorders](https://reader033.fdocuments.net/reader033/viewer/2022061120/546d340cb4af9f7f2c8b535d/html5/thumbnails/44.jpg)
Depression & Pregnancy
• Drug treatment & pregnancy is a tough decision.
• Depression may also occur Post-partum.
Payne, Jenifer L. (2011). Clinical care of Major Depression during pregnancy. Starts at 31:20: http://videocast.nih.gov/Summary.asp?File=16674